123 related articles for article (PubMed ID: 20724944)
1. Cancer-associated retinopathy in neuroendocrine carcinoma of the fallopian tube.
Raghunath A; Adamus G; Bodurka DC; Liu J; Schiffman JS
J Neuroophthalmol; 2010 Sep; 30(3):252-4. PubMed ID: 20724944
[TBL] [Abstract][Full Text] [Related]
2. Value of adjuvant chemotherapy and informed microscopic examination for occult gynecologic cancer detected upon risk-reducing salpingo-oophorectomy after chemotherapy for BRCA1/2-associated breast cancer: a case report.
Kuji S; Kondo H; Ohara T; Deura I; Tozawa-Ono A; Migita O; Kawamoto H; Tsugawa K; Chosokabe M; Koike J; Maeda I; Suzuki N
Jpn J Clin Oncol; 2021 Mar; 51(3):492-497. PubMed ID: 33377156
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel and carboplatin for large cell neuroendocrine carcinoma of the uterine cervix.
Tangjitgamol S; Manusirivithaya S; Choomchuay N; Leelahakorn S; Thawaramara T; Pataradool K; Suekwatana P
J Obstet Gynaecol Res; 2007 Apr; 33(2):218-24. PubMed ID: 17441901
[TBL] [Abstract][Full Text] [Related]
4. [Cancer-associated retinopathy (CAR) in neuroendocrine carcinoma of the uterus].
Siggel R; Schick T; Grajewski RS; Liakopoulos S
Ophthalmologe; 2019 May; 116(5):456-458. PubMed ID: 29931395
[TBL] [Abstract][Full Text] [Related]
5. Primary transitional cell carcinoma of the fallopian tube.
Elsokkari I; Napaki S; Greening S; Aghmesheh M
J Obstet Gynaecol Res; 2011 Nov; 37(11):1767-71. PubMed ID: 21793996
[TBL] [Abstract][Full Text] [Related]
6. A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma.
Abaid LN; Micha JP; Rettenmaier MA; Brown JV; Mendivil AA; Lopez KL; Goldstein BH
Cancer Chemother Pharmacol; 2013 Jul; 72(1):101-7. PubMed ID: 23660691
[TBL] [Abstract][Full Text] [Related]
7. Management of bilateral fallopian tube carcinoma coexistent with tuberculous salpingitis.
Ingec M; Erdogan F; Kumtepe Y; Isaoglu U; Gundogdu C; Kadanali S
J Obstet Gynaecol Res; 2005 Feb; 31(1):65-7. PubMed ID: 15669995
[TBL] [Abstract][Full Text] [Related]
8. Primary clear cell carcinoma of a paratubal cyst: a case report with literature review.
Hwang JH; Song SH; Shin BK; Lee JK; Lee NW; Lee KW
Aust N Z J Obstet Gynaecol; 2011 Jun; 51(3):284-5. PubMed ID: 21631454
[No Abstract] [Full Text] [Related]
9. Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.
Karatsai E; Robson AG; Taylor SRJ
JAMA Ophthalmol; 2019 May; 137(5):564-567. PubMed ID: 30896772
[TBL] [Abstract][Full Text] [Related]
10. Primary carcinoma of the fallopian tube in a 88 years old woman: review of the literature.
Sonmezer M; Ustun Y; Gungor M; Ensari A; Ortac F
Indian J Cancer; 2001; 38(2-4):61-4. PubMed ID: 12593439
[TBL] [Abstract][Full Text] [Related]
11. Recurrent metastatic fallopian tube carcinoma in pregnancy.
Adolph A; Le T; Khan K; Biem S
Gynecol Oncol; 2001 Apr; 81(1):110-2. PubMed ID: 11277660
[TBL] [Abstract][Full Text] [Related]
12. Ovarian large cell neuroendocrine carcinoma in the youngest woman.
Kwon YS; Im KS; Choi DI
Eur J Gynaecol Oncol; 2016; 37(2):244-6. PubMed ID: 27172753
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy consisting of paclitaxel and carboplatin benefits a patient with malignant mixed müllerian tumor of the fallopian tube.
Kawaguchi W; Itamochi H; Kigawa J; Kanamori Y; Oishi T; Shimada M; Sato S; Sato S; Terakawa N
Int J Clin Oncol; 2008 Oct; 13(5):461-3. PubMed ID: 18946759
[TBL] [Abstract][Full Text] [Related]
14. Intravenous/intraperitoneal paclitaxel and intraperitoneal carboplatin in patients with epithelial ovarian, fallopian tube, or peritoneal carcinoma: a feasibility study.
Nagao S; Iwasa N; Kurosaki A; Nishikawa T; Ohishi R; Hasegawa K; Goto T; Fujiwara K
Int J Gynecol Cancer; 2012 Jan; 22(1):70-5. PubMed ID: 22146766
[TBL] [Abstract][Full Text] [Related]
15. Sister Mary Joseph's nodule as the first presenting sign of primary fallopian tube adenocarcinoma.
Kirshtein B; Meirovitz M; Okon E; Piura B
J Minim Invasive Gynecol; 2006; 13(3):234-6. PubMed ID: 16698532
[TBL] [Abstract][Full Text] [Related]
16. Primary Mucinous Carcinoma of the Fallopian Tube: Case Report and Review of Literature.
Wheal A; Jenkins R; Mikami Y; Das N; Hirschowitz L
Int J Gynecol Pathol; 2017 Jul; 36(4):393-399. PubMed ID: 27662036
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel and carboplatin therapy in stage I fallopian tube carcinoma.
Gungor T; Altundag OB; Ustunyurt E; Mollamahmutoglu L
Int J Gynaecol Obstet; 2006 Nov; 95(2):163-4. PubMed ID: 16828094
[No Abstract] [Full Text] [Related]
18. Survival and prognostic factors of patients with primary fallopian tube cancer receiving adjuvant paclitaxel and carboplatin chemotherapy.
Kietpeerakool C; Srisomboon J; Phongsaranantakul S; Khunamornpong S; Cheewakriangkrai C; Sribanditmongkol N
J Obstet Gynaecol Res; 2014 Mar; 40(3):806-11. PubMed ID: 24738123
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated retinopathy in a child with Langerhans cell histiocytosis.
Hayashi M; Hatsukawa Y; Yasui M; Yanagihara I; Ohguro H; Fujikado T
Jpn J Ophthalmol; 2007; 51(5):393-396. PubMed ID: 17926119
[No Abstract] [Full Text] [Related]
20. Modulation of platinum sensitivity and resistance by cyclosporin A in refractory ovarian and fallopian tube cancer patients: a phase II study.
Chambers SK; Davis CA; Schwartz PE; Kohorn EI; Chambers JT
Clin Cancer Res; 1996 Oct; 2(10):1693-7. PubMed ID: 9816118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
